Eyenovia Inc Cash Flow Conversion Efficiency
Eyenovia Inc cash flow conversion efficiency. Based on the latest financial reports, Eyenovia Inc (EYEN) has a cash flow conversion efficiency ratio of 0.457x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.44 Million) by net assets ($-9.71 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Eyenovia Inc (2015–2024)
Cash flow conversion efficiency of Eyenovia Inc from 2015 to 2024. This chart illustrates how Eyenovia Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Eyenovia Inc (EYEN) share price today for real-time trading data and today's change.
Eyenovia Inc Cash Flow Conversion Ratio Explained
Eyenovia Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Eyenovia Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eyenovia Inc ranked by their cash flow conversion efficiency. Also see Eyenovia Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Global Connections Public Company Limited
BK:GC
|
0.045x |
|
Innovate Corp
NYSE:VATE
|
-0.196x |
|
Orma Orman Mahsulleri Integre Sanayi ve Ticaret AS
IS:ORMA
|
0.013x |
|
Holland Colours NV
AS:HOLCO
|
-0.010x |
|
Qualicorp Consultoria e Corretora de Seguros S.A
SA:QUAL3
|
-0.027x |
|
Sab Zenzele Kabili Holdings
JSE:SZK
|
0.020x |
|
JITF Infralogistics Limited
NSE:JITFINFRA
|
0.364x |
|
Pmv Pharmaceuticals Inc
NASDAQ:PMVP
|
-0.204x |
Annual Cash Flow Conversion Efficiency for Eyenovia Inc (2015–2024)
The table below shows the annual cash flow conversion efficiency of Eyenovia Inc from 2015 to 2024. Review how much free cash does Eyenovia Inc generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-13.10 Million | $-30.12 Million | 2.300x | +186.83% |
| 2023-12-31 | $9.00 Million | $-23.84 Million | -2.649x | -81.83% |
| 2022-12-31 | $17.23 Million | $-25.11 Million | -1.457x | -42.82% |
| 2021-12-31 | $20.47 Million | $-20.87 Million | -1.020x | -144.49% |
| 2020-12-31 | $15.30 Million | $-6.38 Million | -0.417x | +74.11% |
| 2019-12-31 | $11.74 Million | $-18.92 Million | -1.611x | -107.41% |
| 2018-12-31 | $16.88 Million | $-13.11 Million | -0.777x | +16.40% |
| 2017-12-31 | $5.09 Million | $-4.73 Million | -0.929x | +12.70% |
| 2016-12-31 | $3.01 Million | $-3.20 Million | -1.065x | +33.35% |
| 2015-12-31 | $2.40 Million | $-3.83 Million | -1.597x | -- |
About Eyenovia Inc
Eyenovia, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vi… Read more